Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between “reality” and “illusion”?

Heerim Nam, Jae Myoung Noh, Seung Gyu Park, Yong Chan Ahn

Abstract

The concept of “oligometastatic state” has long been proposed and recognized based on several important clinical data (1-3). We have witnessed a growing concern and interest, and there are many publications that reported the clinical benefits by applying aggressive local therapy, in addition to the so-called standard palliative management policy among the patients with oligometastatic disease.